Example: marketing

ACG 2018 ANNUAL SCIENTIFIC MEETING OCTOBER …

Discuss best practices in the evaluation of acute kidney injury in patients with liver cirrhosis, and guideline recommendations for the management of hepatorenal syndrome.

Tags:

  Guidelines

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Text of ACG 2018 ANNUAL SCIENTIFIC MEETING OCTOBER …

1 | Page ACG 2018 ANNUAL SCIENTIFIC MEETING OCTOBER 5 10, 2018 Pennsylvania Convention Center Philadelphia, Pennsylvania FRIDAY, OCTOBER 5, 2018 6:00 am 5:00 pm Registration 6:30 am 7:30 am Continental Breakfast for Friday Courses 7:00 am 12:30 pm Pathology and Imaging Course 7:30 am 3:30 pm ASGE Endoscopy Course 7:30 am 4:30 pm Practice Management Course 1:45 pm 5:00 pm What s New in GI Pharmacology 5:00 pm 9:00 pm Navigating, Networking, and Negotiating Your First Job Workshop SATURDAY, OCTOBER 6, 2018 7:00 am 5:15 pm Registration 7:00 am 7:45 am Continental Breakfast for Postgraduate Course 7:50 am 5:00 pm Postgraduate Course 10:00 am 10:30 am David Sun Lecture 12:20 pm 1:35 pm Optional Learning Luncheons 12:20 pm 1:35 pm Career Opportunities for Women in GI Luncheon 5:15 pm 7:00 pm GI Jeopardy SUNDAY, OCTOBER 7, 2018 7:00 am 6:30 pm Registration 7:00 am 7:45 am Continental Breakfast for Postgraduate Course 7:50 am 5:00 pm Postgraduate Course 8:00 am 10:00 am Auxiliary Registration/Hospitality Suite 12:20 pm 1:35 pm Optional Learning Luncheons 12:20 pm 1:35 pm Trainees Luncheon 3:30 pm 7:00 pm Exhibit Hall Opens 3:30 pm 7:00 pm Hands-on Endoscopy Workshop Center 3:30 pm 7:00 pm ACG Job Forum 3:30 pm 7:00 pm Scientific Poster Session 5:15 pm 6:00 pm NP/PA Attendee Reception 5:15 pm 6:00 pm International Attendee Reception 5:15 pm 6:00 pm Women and Minorities in GI Reception 5:15 pm 6:00 pm Exhibitor Theater 5:15 pm 6:30 pm Poster Session Authors Present 5:15 pm 7:00 pm Opening Welcome Reception 6:15 pm 7:00 pm Exhibitor Theater 2 | Page MONDAY, OCTOBER 8, 2018 6:00 am 5:00 pm Registration 6:30 am 7:45 am Optional Breakfast Sessions (4 Monday Breakfasts) Breakfast A: Advances in the Management of Cirrhosis and Portal Hypertension Moderator: Arun J. Sanyal, MD Evaluation of Acute Kidney Injury in a Cirrhotic Patient: HRS and Beyond Arun J. Sanyal, MD Discuss best practices in the evaluation of acute kidney injury in patients with liver cirrhosis, and guideline recommendations for the management of hepatorenal syndrome. Management of Hepatic Encephalopathy Apply current and evolving guidelines for the diagnosis and management of occult and overt hepatic encephalopathy. Optimizing Your Patient With Ascites Nahum Mendez Sanchez, MD, MSc, PhD, FACG Outline a stepwise approach to managing a patient with ascites. Breakfast B: On the Wards Challenges in the Hospitalized Patient Moderator: Kathy P. Bull-Henry, MD, FACG Refractory Small Bowel Bleeding Kathy P. Bull-Henry, MD, FACG Describe the approach to management of hospitalized patients with refractory small bowel bleeding. Abdominal Pain in Complicated Pancreatitis Darwin L. Conwell, MD, MS Explain the management of hospitalized patients with complicated pancreatitis, including necrotizing pancreatitis and fluid collections. Management of Constipation, Ileus, and Narcotic Bowel Melissa Latorre, MD, MS Discuss the timely management of hospitalized patients with generalized GI dysmotility with nausea, vomiting, chronic abdominal pain, and constipation. Breakfast C: Concepts and Controversies in Diverticular Disease Moderator: Neil H. Stollman MD, FACG Acute Diverticulitis: Can We Prevent It, How Best to Treat It, and Can We Decrease Its Recurrence? Neil H. Stollman, MD, FACG Identify risk factors for diverticulitis, possible interventions to prevent and treat it, and the changing role of antibiotics. Diverticular Bleeding: Can We Prevent It, How Best to Treat It, and Can We Decrease Its Recurrence? Lisa L. Strate, MD, MPH, FACG Explain risk factors for diverticular bleeding, as well as possible interventions to prevent and treat it. SUDD and SCAD: Are They Entities in Their Own Right, and How Should We Treat Them? Brennan M. R. Spiegel, MD, MSHS, FACG Discuss the emerging entities of SUDD and SCAD and their possible clinical outcomes and interventions. 3 | Page Breakfast D: Case-based Functional GI Testing: Ask the Experts Moderator: Mark Pimentel, MD, FACG Esophageal Motility and pH Testing John E. Pandolfino, MD, MSCI, FACG Illustrate the key factors related to the performance and interpretation of esophageal motility and pH testing. Breath Testing Mark Pimentel, MD, FACG Summarize the updated consensus recommendations on breath testing and describe clinical applications. Pelvic Floor Testing Amy E. Foxx-Orenstein, DO, MACG Discuss common diagnostic tests and their interpretation for anorectal disorders. 7:50 am 6:00 pm Annual Scientific Meeting 7:50 am 8:00 am Opening Remarks Irving M. Pike, MD, FACG, ACG President 8:00 am 9:00 am Presidential Plenary Session 1 Moderators: Irving M. Pike, MD, FACG Seth A. Gross, MD, FACG Papers 1-5 5 Oral Abstracts 12 min each (9 min per presentation and 3 min Q & A) 9:00 am 9:30 am ACG s Presidential Address Irving M. Pike, MD, FACG Introduced by: Sunanda V. Kane, MD, MSPH, FACG, ACG President-Elect 9:30 am 10:30 am Presidential Plenary Session 2 Moderators: Sunanda V. Kane, MD, MSPH, FACG Seth A. Gross, MD, FACG Papers 6-10 5 Oral Abstracts 12 min each (9 min per presentation and 3 min Q & A) 10:00 am 4:45 pm Exhibit Hall Open 10:00 am 4:45 pm Hands-on Endoscopy Workshop Center 10:30 am 11:30 am Break Visit Exhibit Hall and Browse Scientific Posters 10:30 am 11:30 am Exhibitor Theater 10:30 am 4:15 pm Scientific Poster Session Open 4 | Page 11:30 am 12:45 pm Simultaneous Symposia Session 1 Symposium 1A: Conundrums of the Esophagus Moderator: Fouad J. Moawad, MD, FACG I Think It s Stuck in My Gullet: Managing Dysphagia Ikuo Hirano, MD, FACG Discuss the stepwise approach to managing a patient with difficulty swallowing. The EoE Spectrum: From the Clinically Responsive to the Refractory Patient Fouad J. Moawad, MD, FACG Recognize both the medical and endoscopic therapeutic treatment endpoints for EoE. PPIs: Friend or Foe? Paul Moayyedi, MB ChB, PhD, MPH, FACG Identify the risks of long-term PPI use and weigh them against the benefits. Symposium 1B: Update in CRC Screening Moderator: Joseph C. Anderson, MD, FACG CRC Screening Outside the ASC: Non-invasive Testing Douglas J. Robertson, MD, MPH Discuss the performance characteristics of stool (FIT and fecal DNA) and serum-based testing including implications of a positive test and a normal colonoscopy. The Cutting Edge of Serrated Polyps Joseph C. Anderson, MD, FACG Identify the biology, diagnosis, and classification of serrated polyps, as well as optimal detection, resection and surveillance of them. Thinking Big About Small Lesions Thomas F. Imperiale, MD Describe the management of small adenomas including detection, resection, and surveillance, and new concepts such as optical diagnosis and resect and discard. Symposium 1C: Advances in Non-Alcoholic Fatty Liver Disease (NAFLD) Moderator: Naga P. Chalasani, MD, FACG Initial Work-up and Evaluation of a Patient With NAFLD Naga P. Chalasani, MD, FACG Describe an evidence-based approach for the general gastroenterologist in the initial screening, diagnosis, work-up, and staging of patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Current Management of NAFLD/NASH: Medical, Endoscopic, and Surgical Therapies Zobair M. Younossi, MD, MPH, FACG Discuss current guidelines for the management and treatment of non-alcoholic steatohepatitis (NASH), including medical, endoscopic, and surgical therapies. Future Therapies for NAFLD/NASH Arun J. Sanyal, MD Summarize evolving and future strategies for NASH treatment including clinical trial data and implications for clinical practice. 5 | Page 12:45 pm 2:15 pm Lunch Break Visit Exhibit Hall and Browse Scientific Posters 12:45 pm 2:15 pm ACG FDA Public Forum 12:45 pm 1:20 pm Exhibitor Theater 1:00 pm 2:15 pm Poster Session Authors Present 1:40 pm 2:15 pm Exhibitor Theater 2:15 pm 3:00 pm Simultaneous Plenary Sessions 1 Simultaneous Plenary Session 1A Papers 11-14 4 Oral Abstracts 10 min each (7 min per presentation and 3 min Q & A) Simultaneous Plenary Session 1B Papers 15-18 4 Oral Abstracts 10 min each (7 min per presentation and 3 min Q & A) 3:15 pm 3:45 pm The American Journal of Gastroenterology Lecture Introduced by: Brennan Spiegel, MD, MSHS, FACG 3:45 pm 4:45 pm Break Visit Exhibit Hall 3:45 pm 4:45 pm Exhibitor Theater 4:00 pm 5:00 pm ACG Publishing Symposium Brennan Spiegel, MD, MSHS, FACG, and David C. Whitcomb, MD, PhD, FACG 4:45 pm 6:00 pm Simultaneous Symposia Session 2 Symposium 2A: Is There Consensus: Challenging Cases in IBD Moderator: Sunanda V. Kane, MD, MSPH, FACG Managing Ulcerative Colitis in the Sick Outpatient Sunanda V. Kane, MD, MSPH, FACG Illustrate the importance of a systematic approach to management of complicated ulcerative colitis patients. Crohn s Disease Complicated by an Intraabdominal Abscess What First? Poke, Prod, or Cut? Miguel D. Regueiro, MD, FACG Recognize the different approaches to managing the patient with complicated Crohn s disease. Perianal CD When Anti-TNF Therapy Is Not Enough David A. Schwartz, MD, FACG Describe the treatment options available for complicated perianal Crohn s disease. 6 | Page Symposium 2B: How to Handle Tough Functional Disorders What To Do When Typical Treatments Fail Moderator: Amy S. Oxentenko, MD, FACG Burning, Chest Pain, Nausea, and Vomiting John O. Clarke, MD Formulate diagnostic and management algorithms for functional upper gastrointestinal symptoms. Bloating, Belching, and Abdominal Distention Amy S. Oxentenko, MD, FACG Summarize different diagnostic and therapeutic approaches in the management of functional excess gas. ACG IBS Treatment Monograph: What You Need To Know Eamonn M. M. Quigley, MD, MACG Discuss current strategies around the diagnosis and management of irritable bowel syndrome. Symposium 2C: Live From Philadelphia! The 6th Annual Endoscopy Video Forum Moderators: Seth A. Gross, MD, FACG and Vivek Kaul, MD, FACG Judges: Douglas G. Adler, MD, FACG, Qiang Cai, MD, PhD, FACG, Laith H. Jamil, MD, FACG, Harshit S. Khara, MD, FACG, Shivangi T. Kothari, MD, FACG, and Reem Z. Sharaiha, MD, MSc Demonstrate interesting endoscopic findings and techniques encountered in daily clinical practice. 6:00 pm 6:30 pm ACG s Annual Business Meeting All Members and Fellows of ACG are invited. 6:30 pm Adjourn for the Day 7 | Page TUESDAY, OCTOBER 9, 2018 6:00 am 5:00 pm Registration 6:45 am 8:15 am Optional Breakfast Sessions (8 Tuesday Breakfasts) Breakfast E: Quality and Technique in Colonoscopy: Doing It Better Moderator: Jason B. Samarasena, MD, FACG Pre-procedural Quality: Getting Them In and Getting Them Clean Jason B. Samarasena, MD, FACG Discuss interventions to improve colonoscopy preparation quality and patient tolerance, and ways to reduce procedure cancellation through use of navigators, apps, and improved dietary restrictions. Intra-procedural Quality: Technology, Techniques, and Tips to Improve Effectiveness Seth A. Gross, MD, FACG Describe the current tools and techniques used to improve quality during a colonoscopy, including assistive devices, water techniques, and computer analysis. Post-procedural Quality: How Did We Do and Can We Do Better? Irving M. Pike, MD, FACG Summarize quality metrics such as ADR, withdrawal, surveillance intervals, adverse event tracking, and other possible interventions to increase quality. Breakfast F: Hot Topics in Liver Disease Moderator: Renuka Umashanker, MD, FACG Approach to the Patient With Solid and Cystic Liver Lesion Renuka Umashanker, MD, FACG Outline current guideline recommendations in the evaluation, diagnosis, and management of patients with new liver lesions. Autoimmune Liver Disorders: PBC, PSC, Autoimmune Hepatitis David E. Bernstein, MD, FACG Discuss current and evolving diagnostic and treatment strategies in the management of autoimmune liver disorders, and the application of new therapeutic modalities in clinical practice. Evaluation of a Patient With Alcoholic Liver Disease Vijay H. Shah, MD, FACG Summarize current guidelines in the management of patients with alcoholic liver disease, and discuss evidence-based strategies for implementation in clinical practice. 8 | Page Breakfast G: GERD Weighing the Risks and Benefits Moderator: Philip O. Katz, MD, MACG GERD Diagnostics Complementary Not Competitive C. Prakash Gyawali, MD, FACG Summarize the available techniques and develop a management algorithm for the diagnosis of GERD. Personalized GERD Management Rena H. Yadlapati, MD Describe the role of medical, endoscopic, or surgical management based on GERD phenotypes. Proton Pump Inhibitors: How to Help Get Your Patients Off of Them Philip O. Katz, MD, MACG Identify possible strategies to help your patients discontinue the use of PPIs. Breakfast H: Optimizing IBD Management Moderator: Laura E. Raffals, MD, FACG Treating to Target What Exactly Should Our Target Be Now? Kara M. De Felice, MD Define the concept of treat-to-target for patients with IBD. Looking Into the IBD Crystal Ball Predicting the Course of Disease Laura E. Raffals, MD, FACG Evaluate available tools for predicting disease course in patients with IBD. Choosing the Right Therapy For Your Newly Diagnosed IBD Patient Adam S. Cheifetz, MD, FACG Identify how to select the best initial therapy for your patient with IBD. 9 | Page Breakfast I: Endoscopic Management of Perforations and Fistulae A Didactic Presentation With a Hands-on Workshop Component (talks 10 min each) Moderator: Laith H. Jamil, MD, FACG Strategies for Chronic Fistulae Christopher C. Thompson, MD, MSc, FACG Describe endoscopic techniques available for managing chronic fistulae. Medical and Endoscopic Management of Luminal Perforations Laith H. Jamil, MD, FACG Discuss both medical and endoscopic tools and techniques available for managing luminal perforations. Hands-on Demonstration in the Exhibit Hall Breakfast J: Esophageal Endotherapy Moderator: Gary W. Falk, MD, MS, FACG Barrett s Esophagus: Burn, Freeze, or Cut? Gary W. Falk, MD, MS, FACG Describe techniques of RFA, cryoablation, and EMR/ESD, as well as pros and cons, indications, and outcomes of each technique for treating Barrett s esophagus. Achalasia: Inject, Dilate, or Cut? Walter W. Chan, MD Evaluate techniques of botox injection, pneumatic dilation, and POEM, as well as pros and cons, indications, and outcomes of each technique in treating achalasia. Strictures: Dilate, Cut, or Stent? Mihir S. Wagh, MD, FACG Compare techniques of dilation, endoscopic incisional therapy, and stenting for benign and malignant esophageal strictures, as well as pros and cons, indications, and outcomes of each technique. Breakfast K: Pancreaticobiliary Moderator: Vivek Kaul, MD, FACG Management of Acute Pancreatitis: The First 48 Hours Identify the guidelines and evidence-based early management of patients with acute pancreatitis and how it impacts outcome. ERCP Complications: Prediction, Prevention, and Management Vivek Kaul, MD, FACG Describe how to best predict, prevent, and manage ERCP complications based on current scientific evidence and guidelines. Management of Complex Common Bile Duct Stones Mansour A. Parsi, MD Discuss the state-of-the-art approach to management of large and difficult to remove common bile duct stones. 10 | Page Breakfast L: What Is New in Enteropathy? Moderator: William D. Chey, MD, FACG Diagnosis and Management of Celiac Disease Joseph A. Murray, MD, FACG Discuss the diagnosis and management of celiac disease and its mimics. Non-celiac Gluten Sensitivity William D. Chey, MD, FACG Describe the diagnosis and management of patients with non-celiac gluten sensitivity. What Is New in Leaky Gut? Julia J. Liu, MD, FACG Outline laboratory and endoscopic findings of leaky gut, and recognize the role of leaky gut in the pathogenesis of chronic intestinal disease. 8:30 am 6:25 pm Annual Scientific Meeting 8:30 am 10:00 am Simultaneous Plenary Sessions 2 Plenary Session 2A: Papers 19-27 9 Oral Abstracts 10 min each (7 min per presentation and 3 min Q & A) Plenary Session 2B: Papers 28-36 9 Oral Abstracts 10 min each (7 min per presentation and 3 min Q & A) 10:00 am 4:30 pm Exhibit Hall Open 10:05 am 10:35 am ACG s J. Edward Berk Distinguished Lecture Fake News and Alternative Facts on Personalized Medicine in IBD Discuss best practices in IBD and differentiate the supporting evidence from the current misinformation and misunderstandings that detract from optimal patient care. Stephen B. Hanauer, MD, FACG Introduced by: Irving M. Pike, MD, FACG, ACG President 10:35 am 11:30 am Break Visit Exhibit Hall and Browse Scientific Posters 10:15 am 4:30 pm Hands-on Endoscopy Workshop Center 10:35 am 4:00 pm Scientific Poster Session Open 10:35 am 11:30 am Exhibitor Theater 11 | Page 11:30 am 12:45 pm Simultaneous Symposia Session 3 Symposium 3A: Current Challenges and Controversies in the Management of Viral Hepatitis Moderator: Sonali Paul, MD How to Use Non-invasive Liver Fibrosis Tests in Clinical Practice Sonali Paul, MD Identify the appropriate use of non-invasive liver fibrosis tests, such as serum fibrosis assays and imaging-based elastography, in clinical practice for patients with viral hepatitis and other chronic liver disorders. Challenges in Hepatitis C Management: DAA Failures, Special Populations, and Controversies Mitchell L. Shiffman, MD, FACG Describe the evidence addressing current challenges and controversies in HCV therapy, including treatment of DAA failures and special populations, and the association between DAAs and both HCC and HBV reactivation. Challenges in Hepatitis B Management: HBV Reactivation James S. Park, MD, FACG Discuss evidence-based approaches to challenging issues in hepatitis B management, including the care of chronic HBV in pregnancy, and the evaluation, prevention, and management of HBV reactivation in patients undergoing immunosuppressive drug therapy. Symposium 3B: Battling Physician Burnout: It Will Take a Village Moderator: Carol A. Burke, MD, FACG Recognizing Burnout Christina M. Surawicz, MD, MACG Recognize and identify burnout predictors. What Can Your Institution or Practice Do? Joseph C. Anderson, MD, FACG Describe what your institution or practice can do to mitigate burnout. The Pathway to Physician Wellness Carol A. Burke, MD, FACG Identify ways to have work-life balance. 12:45 pm 2:15 pm Lunch Break Visit Exhibit Hall and Browse Scientific Posters 12:45 pm 1:20 pm Exhibitor Theater 1:00 pm 2:15 pm Poster Session Authors Present 1:40 pm 2:15 pm Exhibitor Theater 2:15 pm 3:45 pm Simultaneous Plenary Sessions 3 Plenary Session 3A: Papers 37-45 9 Oral Abstracts 10 min each (7 min per presentation and 3 min Q & A) Plenary Session 3B: Papers 46-54 9 Oral Abstracts 10 min each (7 min per presentation and 3 min Q & A) 12 | Page 3:45 pm 4:30 pm Break Visit Exhibit Hall and Browse Scientific Posters 4:30 pm 5:00 pm ACG s Emily Couric Memorial Lecture 80% Colorectal Cancer Screening by 2018: How Did We Do and Where Do We Go From Here? Describe the goals of the 80% by 2018 campaign for colorectal cancer screening, the successes it has achieved, and plans for the future. David A. Greenwald, MD, FACG Introduced by: Irving M. Pike, MD, FACG, ACG President 5:00 pm 5:10 pm Break 5:10 pm 6:25 pm Simultaneous Symposia Session 4 Symposium 4A: Interdisciplinary Management of Variceal Bleeding Moderator: Guadalupe Garcia-Tsao, MD, FACG Medical Management of Portal Hypertensive Bleeding Guadalupe Garcia-Tsao, MD, FACG Describe medical management of variceal bleeding as well as its appropriate surveillance. Comprehensive Endoscopic Management of Esophageal and Gastric Varices Assess standard as well as state-of-the-art endoscopic and EUS-guided techniques for managing esophageal and gastric variceal bleeding. The Role of Interventional Radiology in the Management of Variceal Bleeding Michael C. Soulen, MD; (Non-member Radiologist ) Interpret radiology techniques as well as appropriate indications to manage esophageal and gastric variceal bleeding. Symposium 4B: The Colonic Microbiome: C. difficile and Beyond Moderator: Lawrence J. Brandt, MD, MACG The Colonic Microbiome: What Do We Know in 2018? Lawrence J. Brandt, MD, MACG Elaborate on the current state of knowledge about the human microbiome; can we test, can we manipulate? Fecal Microbiota Transplant (FMT) in C. difficile infection Colleen R. Kelly, MD, FACG Explain the biology, technique, and outcomes of FMT in patients with C. difficile infection. Fecal Microbiota Transplant (FMT) for Other Emerging Indications: Potential and Promise Paul Moayyedi, MD, MB ChB, PhD, MPH, FACG Discuss the emerging data on the efficacy of FMT for other indications beyond C. difficile, including IBD, IBS, obesity, and hepatic encephalopathy. 13 | Page Symposium 4C: Burning Issues in Barrett s Esophagus Moderator: Prasad G. Iyer, MD, FACG Screening and Surveillance Why and How? Prasad G. Iyer, MD, FACG Recognize indications for screening and list surveillance recommendations for BE. Predicting Progression to Cancer The Holy Grail Nicholas J. Shaheen, MD, MPH, FACG Describe clinical features and biomarkers associated with progression to high grade dysplasia / cancer in Barrett s esophagus. Tackling Issues in Endoscopic Therapy Vani Konda, MD Discuss issues relevant to the management of BE patients without dysplasia, with low grade dysplasia, and after successful ablation. 6:25 pm Adjourn for the Day 14 | Page WEDNESDAY, OCTOBER 10, 2018 6:30 am 12:15 pm Registration 6:45 am 8:15 am Optional Breakfast Sessions (4 Wednesday Breakfasts) Breakfast M: The End of the Road: A Primer on Anorectal Disorders Moderator: Arnold Wald, MD, MACG Ouch: Diagnosis and Treatment of Hemorrhoids and Anal Fissures Arnold Wald, MD, MACG Elaborate on current state of knowledge on the diagnosis and non-procedural treatments for hemorrhoids and anal fissures. Oy, I t s Not Working Right: Defecatory Dysfunction Amy E. Foxx-Orenstein, DO, MACG Describe the pathophysiology and treatment of impaired defecation including incontinence and dysynergy. But Can We Fix It? Anorectal Interventions for the Gastroenterologist Harry E. Sarles, Jr., MD, FACG Discuss possible anorectal interventions such as banding, injectates, and others. Breakfast N: Esophageal Motility Disorders Moving the Field Forward Moderator: John E. Pandolfino, MD, MSCI, FACG EGJ Outflow Obstruction Don t Count on IRP Abraham R. Khan, MD, FACG Define true pathology from artifact and determine appropriate management for esophagogastric junction obstruction. Personalized Management of Achalasia in the Era of POEM Michael F. Vaezi, MD, PhD, MSc(Epi), FACG Discuss appropriate treatment for manometric phenotypes and personal preferences in patients with achalasia. Borderline Esophageal Motor Function: The Garbage Can of Motility John E. Pandolfino, MD, MSCI, FACG Recognize which esophageal motility disorders are clinically relevant. Breakfast O: The Shift From Humoring to Honoring Your Patient s Questions (Going Beyond Medications) Moderator: Arun C. Swaminath, MD Pot Roast: Do Diet and Marijuana Have a Role in Management of IBD? Arun C. Swaminath, MD Summarize data-based advice regarding diet therapy and marijuana use in the management of IBD. Recognizing and Managing Psychological Problems in the IBD Patient Laurie A. Keefer, PhD Identifying and managing psychological issues in your IBD patient population. Probiotics, Antibiotics, and Stool Transplants (A Gut Hack Manipulating the Microbiome) Colleen R. Kelly, MD, FACG Describe dysbiosis in IBD and interventions to repair it. 15 | Page Breakfast P: Emerging Medical and Surgical Therapies for Gastrointestinal Motility Disorders Moderator: Brooks D. Cash, MD, FACG GERD and Hypercontractile Esophageal Disorders Shivangi T. Kothari, MD, FACG Discuss new advances in medical and surgical therapies for GERD and hypercontractile esophageal disorders. Gastroparesis Explain the mechanisms and evidence regarding new advances in gastroparesis therapy. Constipation and Incontinence Brooks D. Cash, MD, FACG Recognize emerging therapies for functional anorectal disorders. 8:30 am 12:15 pm Annual Scientific Meeting 8:30 am 10:15 am Simultaneous Plenary Session 4 (Free Papers/Abstract Presentations) Plenary Session 4A: Papers 55-64 10 Oral Abstracts 10 min each (7 min per presentation and 3 min Q & A) Plenary Session 4B: Papers 65-74 10 Oral Abstracts 10 min each (7 min per presentation and 3 min Q & A) 10:15 am 10:20 am Break 10:20 am 10:50 am ACG s David Y. Graham Lecture Management of Patients With Colorectal Polyps: A Personalized Approach Based on Etiology Carol A. Burke, MD, FACG Describe the implications of lifestyle, genetics, and polyp characteristics on the management of patients with colorectal polyps. Introduced by: Irving M. Pike, MD, FACG, ACG President 10:50 am 11:00 am Break 16 | Page 11:00 am 12:15 pm Simultaneous Symposia Session 5 Symposium 5A: Pancreatic Neoplasia Moderator: Linda S. Lee, MD Pancreatic Cysts: Navigating the Guidelines Linda S. Lee, MD Apply the ACG Guidelines to the management of pancreatic cysts. Screening for Pancreatic Cancer: 2018 Update Vivek Kaul, MD, FACG Identify the current state of the science for pancreatic cancer screening in high-risk populations. Malignant Masquerades in Pancreatic Disease Christopher J. DiMaio, MD, FACG Describe the various clinical conditions and imaging findings that mimic pancreatic malignancy and how to evaluate and manage these patients. Symposium 5B: ACG Annual Debrief: IBD Highlights at This Year s Annual Meeting Moderator: David T. Rubin, MD, FACG Ulcerative Colitis Medical Management David T. Rubin, MD, FACG Discuss breakthroughs in clinical care for patients with ulcerative colitis. Crohn's Disease Medical Management Gary R. Lichtenstein, MD, FACG, MS, FACG Describe breakthroughs in clinical care for patients with Crohn s disease. 12:15 pm Annual Scientific Meeting Adjourns

Related search queries